Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1233221.RAeGey9FYTYe4HSMhGorqKXGqiNQ9QkgH9hTqT7mVC_Gk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1233221.RAeGey9FYTYe4HSMhGorqKXGqiNQ9QkgH9hTqT7mVC_Gk130_assertion type Assertion NP1233221.RAeGey9FYTYe4HSMhGorqKXGqiNQ9QkgH9hTqT7mVC_Gk130_head.
- NP1233221.RAeGey9FYTYe4HSMhGorqKXGqiNQ9QkgH9hTqT7mVC_Gk130_assertion description "[These results suggest that Liq treatment enhances glioma cell susceptibility to TMZ by inhibiting the PI3K/AKT/mTOR pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233221.RAeGey9FYTYe4HSMhGorqKXGqiNQ9QkgH9hTqT7mVC_Gk130_provenance.
- NP1233221.RAeGey9FYTYe4HSMhGorqKXGqiNQ9QkgH9hTqT7mVC_Gk130_assertion evidence source_evidence_literature NP1233221.RAeGey9FYTYe4HSMhGorqKXGqiNQ9QkgH9hTqT7mVC_Gk130_provenance.
- NP1233221.RAeGey9FYTYe4HSMhGorqKXGqiNQ9QkgH9hTqT7mVC_Gk130_assertion SIO_000772 25351348 NP1233221.RAeGey9FYTYe4HSMhGorqKXGqiNQ9QkgH9hTqT7mVC_Gk130_provenance.
- NP1233221.RAeGey9FYTYe4HSMhGorqKXGqiNQ9QkgH9hTqT7mVC_Gk130_assertion wasDerivedFrom befree-2016 NP1233221.RAeGey9FYTYe4HSMhGorqKXGqiNQ9QkgH9hTqT7mVC_Gk130_provenance.
- NP1233221.RAeGey9FYTYe4HSMhGorqKXGqiNQ9QkgH9hTqT7mVC_Gk130_assertion wasGeneratedBy ECO_0000203 NP1233221.RAeGey9FYTYe4HSMhGorqKXGqiNQ9QkgH9hTqT7mVC_Gk130_provenance.